INVATIN developed the SYNAXIS, a first in class permanent aortic implantable apparatus for diversion of thromboembolic materials away from the brain. The device was developed to address the large population of patients with atrial fibrillation (AF), high stroke risk, and high bleeding risk. Patients that cannot be treated with other measures are the ultimate candidates for the SYNAXIS. Accordingly, it may be used in patients with intra-cardiac thrombi and in patients who are at risk for non-LAA related cerebral embolization. The device confers a new approach towards stroke prevention, and hold several advantages as compared with available technologies and drugs.
The INVATIN's SYNAXIS is a novel one-piece cylindrical endovascular graft consisting of Nitinol frame and detachable filtering unit components. The stent graft is constructed of woven polyester fabric sewn to self-expanding nitinol stents with braided polyester and monofilament PTFE suture. The filter unit is designed and reinforced to sustain a high shearing forces and provide sustainability. The filter unit is positioned to cover all 3 arteries emerging from the aortic arch. Its design enables minimally invasive removal of the filtering apparatus with an intra-vascular biopsy forceps as a bailout procedure, with future application of replacing the filtering unit.
Animal studies have been completed, demonstrating both safety and preclinical efficacy in acute and chronic swine models of cerebral embolism.
Market size of stroke prevention in AF patients is estimated at 11.5B$/year. Several collaborations are being considered with manufacturers and distributors, as well as with traditional medical device companies. Among others, the company received investments from Clalit, the largest Israeli HMO, which may facilitate any local and international implementation.
Company Details
- Founded
- -
- Address
- Barnea St,
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://www.invatin.com/
- Keywords
- Stroke prevention, Permanent stroke prevention, device base stroke prevention, and device alternative for NOAC, device alternative for anticoagulation drugs, device alternative for Atrial Fibrillation.
- HQ
- Katzerin
Invatin Technologies Ltd Questions
Invatin Technologies Ltd's website is http://www.invatin.com/
Invatin Technologies Ltd's LinkedIn profile is https://www.linkedin.com/company/invatin-technologies-ltd
Invatin Technologies Ltd's industry is
Medical Equipment Manufacturing
Invatin Technologies Ltd's top competitors are
San Diego Cardiac Center,
Relisys Medical Devices Limited,
Centenial Surgical Suture Ltd,
Kimal,
Mangogen Pharma,
Aov Biosciences Pvt. Ltd.,
Medepro International,
Adventus Meditech India Pvt Ltd,
Pak Surgical Instruments,
Artivion Emea.
Invatin Technologies Ltd's categories are Medical Equipment Manufacturing
Invatin Technologies Ltd's founding year is 2016
